MD Anderson acquires inducible switch technologies for cell therapy

MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may in

Related Keywords

Houston ,Texas ,United States ,University Of Texas ,Bellicum Go ,Philip Jones ,Katy Rezvani ,Drug Administration ,Research Strategy ,Cancer Center ,Bellicum Pharmaceuticals Inc ,Bellicum Pharmaceuticals ,Therapeutics Discovery ,Stem Cell Transplantation ,